Literature DB >> 16967458

Malignancies in organ transplant recipients.

H Myron Kauffman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16967458     DOI： 10.1002/jso.20579

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  5 in total

Review 1.  Malignancy in kidney transplant recipients.

Authors:  Anil Kapoor
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany.

Authors:  Jan Steffen Jürgensen; Robert Ikenberg; Roger-Axel Greiner; Volker Hösel
Journal:  Eur J Health Econ       Date:  2014-04-13

Review 3.  Renal Cancer in Recipients of Kidney Transplant.

Authors:  Prajwal Dhakal; Smith Giri; Krishmita Siwakoti; Supratik Rayamajhi; Vijaya Raj Bhatt
Journal:  Rare Tumors       Date:  2017-03-24

4.  Analysis of clinicopathological features of papillary thyroid carcinoma in solid organ transplant recipients: a retrospective study.

Authors:  Liang Hu; Yijun Wu; Fangyu Ju; Yaohui Zhang; Weilin Wang
Journal:  Gland Surg       Date:  2022-08

5.  Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis.

Authors:  Vivan Hellström; Gunnar Tufveson; Angelica Loskog; Mats Bengtsson; Gunilla Enblad; Tomas Lorant
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.